3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxo-propanenitrile
Catalog No. :
词条名称 :
Product Type :
Product Level :
Brand :
Cas No. :
Molecular Formula :
Molecular Weight :
MDL No. :
Pack Size | Availability | Purity | Price | User Price | Quantity |
---|---|---|---|---|---|
Sorry, there is no price information yet |


Basic information
GHS | |
---|---|
Exact Mass | 312.16986 |
Smiles | C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)C1C2C=CNC=2N=CN=1 |
别名 | CP 690550;Tofacitinib;Tasocitinib;Tropsch iMatinib;CP 690550(Tasocitinib);Tasocitinib (CP 690550);3-((3R,4R)-4-Methyl-3-(Me...;CP-690550(Tasocitinib,CP690550);Tofacitinib (CP-690550,Tasocitinib);3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-D)pyrimidin-4-yl-, (3R,4R)-;他索替尼;托法替尼;托法替尼碱;托法替尼盐酸盐;托法替尼(游离碱);3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-;(3R,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-BETA-氧代-1-哌啶丙腈;1-哌啶丙腈, 4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-Β-氧代-, (3R,4R)-;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈,(托法替尼碱) |
Character | |
Storage Condition | |
Melting Point | |
Canonical Smiles | CN([C@H]1CN(CC[C@H]1C)C(=O)CC#N)C1=NC=NC2NC=CC=21 |
Flash Point | |
Chemical Stability | |
Density | |
Boiling Point | |
HS Code | |
Chirality | |
Biological Activity | |
Physicochemical Propertie | |
Inchi | InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 |
UN No. | |
Feature | |
Useage | |
InchiKey | UJLAWZDWDVHWOW-YPMHNXCESA-N |
Vapor Pressure | |
Transport Condition |
Security information
Risk Statements | |
---|---|
Signal Word | |
Water Solubility | |
Dangerous Goods | |
Safety Statements | |
Storage Temp. | 贮存在阴凉处。容器保持紧闭,储存在干燥通风处 |
Hazard Codes | |
Hazardous Decomposition Products |
产品介绍
Sorry, there are currently no product details available
Related Literature
Sorry, there is currently no relevant literature available